189 related articles for article (PubMed ID: 6839062)
1. Comparison of the effects of the hypolipidaemic agents ICI53072 and clofibrate with those of phenobarbitone on liver size, blood flow and DNA content in the rat.
Berman JS; Hiley CR; Wilson AC
Br J Pharmacol; 1983 Mar; 78(3):533-41. PubMed ID: 6839062
[TBL] [Abstract][Full Text] [Related]
2. The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid.
Orton TC; Parker GL
Drug Metab Dispos; 1982; 10(2):110-5. PubMed ID: 6124394
[TBL] [Abstract][Full Text] [Related]
3. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
Amacher DE; Beck R; Schomaker SJ; Kenny CV
Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
[TBL] [Abstract][Full Text] [Related]
4. Relationship of serum triglyceride lowering to changes in hepatic composition induced by different classes of drugs.
Dalton C; Hope WC; Hope HR; Sheppard H
Biochem Pharmacol; 1974 Feb; 23(3):685-96. PubMed ID: 4150813
[No Abstract] [Full Text] [Related]
5. Studies on the hepatomegaly caused by the hypolipidemic drugs nafenopin and clofibrate.
Beckett RB; Weiss R; Stitzel RE; Cenedella RJ
Toxicol Appl Pharmacol; 1972 Sep; 23(1):42-53. PubMed ID: 5071041
[No Abstract] [Full Text] [Related]
6. Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid).
Gibson GG; Orton TC; Tamburini PP
Biochem J; 1982 Apr; 203(1):161-8. PubMed ID: 7103935
[TBL] [Abstract][Full Text] [Related]
7. Hepatic effect of two hypolipidemic drugs in rats.
Magnusson G; Magnusson O
Exp Pathol (Jena); 1977; 13(2-3):180-7. PubMed ID: 913535
[TBL] [Abstract][Full Text] [Related]
8. Influence of single and concurrent clofibrate and phenobarbital administration on cytochrome P450-dependent mixed function oxidase activities and peroxisome proliferation in male rat liver.
Close I; Shackleton G; Goldfarb PS; Gibson GG; Sharma R; Howes D
J Biochem Toxicol; 1992; 7(3):193-8. PubMed ID: 1479597
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of four hypolipidaemic agents on the activity of drug-metabolizing enzymes in rat liver microsomes.
Fournel S; Magdalou J; Batt AM; Siest G
Int J Clin Pharmacol Res; 1983; 3(6):431-6. PubMed ID: 6432712
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of benzodioxane, chroman, and dihydrobenzofuran analogs of clofibrate on various parameters of hepatic drug metabolism.
Lewis NJ; Feller DR; Poochikian GK; Witiak DT
J Med Chem; 1974 Jan; 17(1):41-5. PubMed ID: 4808468
[No Abstract] [Full Text] [Related]
11. Phenobarbitone effects on hepatic microsomal enzymes and liver blood flow in the guinea pig.
Yates MS; Hiley CR; Challiner MR; Park BK
Biochem Pharmacol; 1979 Sep; 28(18):2856-7. PubMed ID: 497037
[No Abstract] [Full Text] [Related]
12. [Effects of several antilipemic agents on the activity of liver microsomal enzymes].
Mounié J; Goudonnet H; Escousse A; Truchot RC
J Pharmacol; 1986; 17(3):308-15. PubMed ID: 3491930
[TBL] [Abstract][Full Text] [Related]
13. The effects of tiadenol, clofibrate and clofibride on bile composition in the rat.
Rozé C; Cuchet P; Souchard M; Vaille C; Debray C
Eur J Pharmacol; 1977 May; 43(1):57-64. PubMed ID: 862664
[TBL] [Abstract][Full Text] [Related]
14. Effects of phenobarbitone on hepatic microsomal enzyme activity and liver blood flow in spontaneously hypertensive rats.
Yates MS; Hiley CR; Back DJ
Life Sci; 1979 Feb; 24(6):535-40. PubMed ID: 431334
[No Abstract] [Full Text] [Related]
15. Differential effects of dehydroepiandrosterone and clofibrate on the binding of 7,12-dimethyl benz(a)anthracene to hepatic DNA in vivo--a preliminary study.
Prasanna HR; Hart RW; Magee PN
Drug Chem Toxicol; 1989; 12(3-4):327-35. PubMed ID: 2534380
[TBL] [Abstract][Full Text] [Related]
16. Effect of hypolipidaemic drugs on hepatomegaly and micro-bodies in the rat. A new approach to the nature of hepatic peroxisomal proliferation.
Sim AK; Spencer A; Metz G; Rushton B
Arzneimittelforschung; 1981; 31(7):1119-26. PubMed ID: 7196761
[TBL] [Abstract][Full Text] [Related]
17. Effects of alteration of hepatic microsomal enzyme activity on liver blood flow in the rat.
Nies AS; Wilkinson GR; Rush BD; Strother JR; McDevitt DG
Biochem Pharmacol; 1976 Sep; 25(17):1991-3. PubMed ID: 985528
[No Abstract] [Full Text] [Related]
18. Effects of phenobarbitone and 6-methylprednisolone pretreatment on pressure/flow relations in the superior mesenteric and iliac arterial beds of the rat.
Hiley CR; Nichols AJ; Wilson AC
J Pharm Pharmacol; 1985 Mar; 37(3):164-9. PubMed ID: 2858562
[TBL] [Abstract][Full Text] [Related]
19. Liver blood flow and blood volume following chronic phenobarbitone administration.
Ohnhaus EE; Locher JT
Eur J Pharmacol; 1975 Apr; 31(2):161-5. PubMed ID: 1149789
[TBL] [Abstract][Full Text] [Related]
20. Effects of clofibrate and tiadenol on the elimination of lipids and bile acids in rat bile.
Cuchet P; Morrier C; Cand F; Keriel C
Lipids; 1981 Oct; 16(10):732-8. PubMed ID: 7300592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
